AngelEye Health Unveils AIVision: Elevating Neonatal and Pediatric Care through AI and Computer Vision
'Over the past year, we've moved from vision to execution,' said Christopher Rand, CEO of AngelEye Health. 'With AIVision, we have been actively conducting clinical research and developing AI models designed to integrate into our bedside cameras, transforming these cameras from passive viewing tools into intelligent clinical assets. This innovation positions AngelEye as a pioneer in AI-powered pediatric care.'
AIVision: From Concept to Reality
AngelEye has begun testing its motion analysis algorithms integrated within its existing camera infrastructure, laying the foundation for a suite of screening and decision-support applications. A key catalyst for this effort was the strategic acquisition of the Early Detection Neuromotor Assessment (EDNA) platform in 2024, enabling the training of video models that will assist in identifying neuromotor risk factors, supporting earlier interventions— (pending appropriate regulatory clearance).
At Synova's NICU Leadership Forum, CEO Christopher Rand presented several additional areas under active development within AIVision, including:
Video EEG Synchronization – Pairing video with EEG data to enrich clinical interpretation
Respiratory Status Monitoring – AI-powered analysis of camera and sensor data to detect early signs of respiratory distress, apnea events, and subtle desaturations, supporting timely intervention and escalation of care
Crash/Coding Event Recording – Supporting clinical training and quality improvement initiatives
AI-Assisted Pain and Sedation Insights – Supporting clinical evaluation of neonatal pain, agitation, and sedation
Emerging Concepts – Including skin integrity monitoring, tube dislodgement detection, digital bedrails, and general movement and positioning indices
While many of these technologies are still under research and development and may require FDA clearance before clinical deployment, they represent the company's broader vision and investment in a connected, intelligent NICU environment of the future, providing a richer understanding of pediatric health patterns over time.
With nearly 10,000 bedside cameras deployed across 300+ hospitals, AngelEye has a unique infrastructure, allowing for swift development and efficient deployment of its AI models. This reach ensures AIVision can evolve through real-world scenarios, delivering value at scale.
Empowering the Pediatric Units of Tomorrow
The applicability of AI extends beyond AIVision on the CameraSystem as ambient intelligence is applied to the entire AngelEye Platform including both MilkTracker and NICU2Home.
'By connecting our CameraSystem, feeding management software, and discharge coordination tools through a unified intelligence layer, we're building the most comprehensive neonatal and pediatric AI platform in the industry,' said Patrick Tinsley, PhD, AngelEye's Manager of Medical Technology. 'We're not just capturing moments—we're interpreting them for action.'
Planned AI functionalities include:
Personalized care planning, education, and journey mapping
Identification of risk factors for patients and families
AI-assisted documentation to automate documentation and workflows
Predictive analytics for nutrition and discharge optimization
Automated alerts for environmental and clinical risks
Clinical Collaboration and Strategic Partnerships
AngelEye is already working alongside several talented partners to make the vision of the intelligent pediatric unit a reality. AngelEye Health is actively engaged in a research and data collection project with Nationwide Children's Hospital, layering machine learning over longitudinal patient data, multimodal sensor data, including video, all within the clinical pediatric setting.
Additionally, AngelEye has entered a strategic partnership with NeuroBell, a novel neonatal EEG technology company, to enhance bedside neurological monitoring with synchronized video.
'Leveraging AngelEye's installed base and strong hospital partnerships will allow us to rapidly deploy our critically important neonatal EEG monitor into the market, complete with integrated video capabilities,' said Mark O'Sullivan, CEO of NeuroBell. 'Together, we are enabling a new standard of neurodiagnostics in the NICU.'
Looking Ahead
AngelEye Health invites researchers, clinicians, and health systems to collaborate on next-generation tools and studies that will validate and expand the clinical utility of AI in pediatric units. These partnerships are key to ensuring ethical, evidence-based deployment of machine learning.
If you are interested in accelerating the pediatric unit of the future together, please reach out to research@angeleyehealth.com
About AngelEye Health
AngelEye Health is the leading provider of innovative technology solutions dedicated to transforming neonatal and pediatric care. Trusted by over 300 hospitals globally, AngelEye equips care teams with AI-driven tools designed to streamline workflows, reduce length of stay, minimize errors, and optimize resource allocation. Its comprehensive suite, including CameraSystem for family engagement, MilkTracker for precise feeding management, NICU2Home for efficient discharge planning, and EDNA for proactive risk identification, supports care teams and families at every step of the NICU journey. With a commitment to continuous innovation, AngelEye Health is shaping the NICU of the future, empowering families, enhancing clinical efficiency, and delivering measurable improvements in patient outcomes. To learn more, visit angeleyehealth.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
9 minutes ago
- Business Wire
Tineco Introduces the New FLOOR ONE S7 Stretch Steam: Steam at the Service of Well-being
PARIS--(BUSINESS WIRE)--Tineco, a pioneer in intelligent cleaning solutions, unveils its latest innovation, the FLOOR ONE S7 Stretch Steam. This next-generation vacuum mop combines the natural power of 140 °C steam with an ultra-flexible design and smart technologies. Designed for modern households, this new device cleans and disinfects floors without chemicals, using steam alone. An ecological, effective, and healthy solution that becomes the perfect daily ally for a clean home, even with children or pets. Thanks to its ultra-flat 180° swivel head, it easily slips under low furniture. Its smart sensors automatically adjust the power according to the dirt level for optimal cleaning. No more scrubbing, rinsing, or drying — the FLOOR ONE S7 Stretch Steam does it all by itself. A concentration of technologies for optimal cleaning: HyperSteam steam at 140 °C: removes stains, bacteria, and naturally disinfects Ultra-flat 180° head: perfect for cleaning under low furniture without moving anything Up to 80 minutes autonomy: clean an entire floor without recharging DualBlock™ anti-tangle system: stops hair and fur to prevent blockages Automatic brush cleaning and drying: silent, fast, and hygienic iLoop™ smart sensors: adjust suction power in real time based on dirt levels 3-sided edge cleaning: efficiently reaches baseboards and corners Availability and Pricing The FLOOR ONE S7 Stretch Steam is available now on Amazon France and the official Tineco online store, with a recommended retail price of 699€. The FLOOR ONE S7 Stretch Steam Plus version will be available from early October in Fnac Darty and Boulanger stores, with a recommended retail price of 699 €. Visuals available here About Tineco Tineco ("tin-co") was founded in 1998 with its first product launch as a vacuum cleaner and, in 2019, pioneered the first-ever smart vacuum. Today, the brand has evolved into a global leader in intelligent appliances spanning floor care, kitchen, and personal care categories. With a growing user base of over 19.5 million households and availability in approximately 30 countries worldwide, Tineco remains committed to its brand vision of making life easier through smart technology and continuous innovation. For more information, visit
Business Wire
an hour ago
- Business Wire
Andong Jongga Culture Center to Export Fermented Teas via Mongolian-Gyeongbuk Trade Delegation
ANDONG, South Korea--(BUSINESS WIRE)--The Andong Jongga Culture Center has announced that it will export its fermented teas—ginger and apple—to overseas supermarkets through the Mongolian-Gyeongbuk Comprehensive Trade Delegation. These teas, either patented or patent-pending, are recognized for their exceptional flavor and proven health benefits. 'We plan to continue researching a variety of fermented teas that can serve as nourishing everyday beverages — even as a healthy alternative to water.' Share The fermented ginger tea is particularly noted for its ability to boost immunity and alleviate conditions such as rhinitis and gastritis. Thanks to its high absorption rate, many users report noticeable effects with just a few servings. Its portability and absence of side effects have further strengthened consumer trust. Soonja Lee from the Andong Jongga Culture Center stated, 'We plan to continue researching a variety of fermented teas that can serve as nourishing everyday beverages—even as a healthy alternative to water.' About Andong Jongga Culture Center Since its founding in October 2017, the Andong Jongga Cultural Center has been dedicated to developing and producing premium goods rooted in time-honored traditions passed down through families. By harnessing the richness of local agricultural ingredients—most notably Andong ginger—the center is elevating the value and global appeal of Korea's regional specialties.
Business Wire
3 hours ago
- Business Wire
Meitu Reports Strong First Half 2025 Financial Results as AI Applications Drive Global Growth
HONG KONG--(BUSINESS WIRE)--Meitu, Inc. ( a Hong Kong–listed AI technology company with a focus on the photo and video industry, today announced its unaudited consolidated results for the six months ended June 30, 2025. Adjusted net profit reached RMB 467 million, up 71.3% year-on-year, while total revenue grew 12.3% year-on-year to RMB 1.8 billion, reflecting strong adoption of Meitu's AI-powered photo, video, and design products. These results highlight the impact of the company's strategic focus on 'Productivity and Globalisation.' Paid Subscribers Reach 15.4 Million, Driving Core Revenue Growth Revenue from photo, video, and design products rose 45.2% year-on-year to RMB 1.35 billion, representing over 74% of total revenue. Underpinning this growth is a 42% year-on-year increase of paying subscribers, which reached a new high of 15.4 million with a paying subscription rate of 5.5%. Monthly active users (MAUs) totaled 280 million, up 8.5% year-on-year, as the company's core products Meitu, BeautyCam, and Wink maintained leading positions in China and achieved significant growth in markets outside of Mainland China. Productivity Tools Achieve Strong International Growth Meitu's productivity-focused offerings, such as DesignKit for e-commerce design and Kaipai for AI-assisted video production, recorded over 90% year-on-year growth in MAUs in markets outside of Mainland China, with even faster growth in paying subscribers. In July 2025, Meitu launched its AI design agent RoboNeo that empowers users to create high-quality visual content through intelligent design automation, which quickly gained traction to rank among the top app downloads in Mainland China and several markets outside of Mainland China. International Expansion Strengthens User Base MAUs from markets outside of Mainland China grew by 15.3% year-on-year to 98 million, now accounting for 35% of total MAU, as localized strategies helped apps such as Wink and Vmake achieve significant growth. This included adapting features to local users' preferences, such as popular hair colours in Indonesia and video dubbing habits in Japan. During the first half of 2025, Meitu invested RMB 450 million in research and development through its Meitu Imaging & Vision Lab (MT Lab), underpinning ongoing AI innovation across both leisure and productivity products.
